Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar;8(1):223-31.
doi: 10.1016/j.ccep.2015.10.034.

The Muscle-Bound Heart

Marwan M Refaat  1 , Akl C Fahed  2 , Sylvana Hassanieh  3 , Mostafa Hotait  4 , Mariam Arabi  5 , Hadi Skouri  4 , Jonathan G Seidman  6 , Christine E Seidman  7 , Fadi F Bitar  5 , Georges Nemer  3
Affiliations
Review

The Muscle-Bound Heart

Marwan M Refaat et al. Card Electrophysiol Clin. 2016 Mar.

Abstract

Hypertrophic cardiomyopathy (HCM) is a familial cardiac disease manifested in a wide phenotype and diverse genotype and, thus, presenting unpredictable risks mainly on young adults. Extensive studies are being conducted to categorize patients and link phenotype with genotype for a better management and control of the disease with all its complications. Because the full mechanisms behind HCM are still not revealed, therapeutics are not definitive. Further research is to be conducted for the generation of a complete picture and directed therapy for HCM.

Keywords: Genotype; Hypertrophic cardiomyopathy; Left ventricle; Muscle-bound heart; Phenotype.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Pedigree for the family isshown (circles 5 females; squares 5 males) with affected subjects shown as shaded circles and squares. The arrow marks the proband with HCM.
Figure 2:
Figure 2:
Management algorithm of patients with HCM. 2-D, 2 dimensional; ACEi, angiotensin-converting enzyme inhibitor; LVEF, LV ejection fraction; MRA, magnetic resonance angiography.
See this image and copyright information in PMC

References

    1. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, et al. Report of the 1995 world health Organization/International society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996; 93(5): 841–842. - PubMed
    1. Maron B, Towbin J, Thiene G, Antezelevitch C, Corrado D, et al. Contemporary Definitions and Classification of the CardiomyopathiesAn American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807–1816 - PubMed
    1. Teare D Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958;20(1):1–8 - PMC - PubMed
    1. Bogaert J, Olivotto I MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside. Radiology 2014; 273: 329–348 - PubMed
    1. Maron BJ Hypertrophic cardiomyopathy: An important global disease. Am J Med 2004; 116(1): 63–65. - PubMed

LinkOut - more resources